Literature DB >> 27555208

VivaSight: a new era in the evolution of tracheal tubes.

Ayten Saracoglu1, Kemal T Saracoglu2.   

Abstract

STUDY
OBJECTIVE: To evaluate the available data describing the use of single and double lumen VivaSight tubes.
DESIGN: Systematic review.
SETTING: The use of VivaSight tubes for elective surgeries including advantages, disadvantages, and possible complications. PATIENTS: Systematic review of randomized controlled trials from databases including Medline, Web of Knowledge, Google Scholar, and Cochrane Central Register of Controlled Trials.
INTERVENTIONS: Comparison of VivaSight single and double-lumen tubes with conventional tubes during normal airway and expected difficult airway management. The effectiveness of the devices was also evaluated during 1-lung ventilation for patients undergoing thoracic surgery. MEASUREMENTS: Intubation time, success rate, the requirement for fiberoptic bronchoscope, and the rate of complications. MAIN
RESULTS: Following a VivaSight double-lumen tube, a flexible bronchoscope is still needed. It is difficult to agree that VivaSight tube reduces the need or use of a bronchoscope. According to the current literature, it is unclear if there is any advantage of the VivaSight compared with using flexible bronchoscopy to direct a blocker into the correct lung. The cost may be another issue. Studies comparing VivaSight tubes with standard double lumen tubes reported faster tracheal intubation rate and higher success rate at first attempt for VivaSight. However, VivaSight tubes may cause soft tissue trauma such as bleeding, hematoma, edema, and erythema. Sore throat and dysphonia are other reported complications. Due to the outer thickness, smaller-sized double-lumen tube may be necessary. It has been reported to have the disadvantages, such as melting due to the heat of light source before insertion and sudden shutdown without warning.
CONCLUSIONS: Problems such as overheating and melting on the distal end of the tube due to the light source and potential breakdowns of the cable should be solved by the manufacturer. This will probably require a redesign and necessitate further studies.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Airway; One-lung ventilation; VivaSight

Mesh:

Year:  2016        PMID: 27555208     DOI: 10.1016/j.jclinane.2016.04.034

Source DB:  PubMed          Journal:  J Clin Anesth        ISSN: 0952-8180            Impact factor:   9.452


  6 in total

1.  ETView VivaSight single lumen vs. conventional intubation in simulated studies: a systematic review and meta-analysis.

Authors:  Seok Kyeong Oh; Byung Gun Lim; Young Sung Kim; Jae Hak Lee; Young Ju Won
Journal:  J Int Med Res       Date:  2020-06       Impact factor: 1.671

2.  A Cost-Effectiveness Analysis Comparing the VivaSight Double-Lumen Tube and a Conventional Double-Lumen Tube in Adult Patients Undergoing Thoracic Surgery Involving One-Lung Ventilation.

Authors:  Sara Larsen; Jimmy Højberg Holm; Tove Nørgaard Sauer; Claus Andersen
Journal:  Pharmacoecon Open       Date:  2020-03

Review 3.  Optical Devices in Tracheal Intubation-State of the Art in 2020.

Authors:  Jan Matek; Frantisek Kolek; Olga Klementova; Pavel Michalek; Tomas Vymazal
Journal:  Diagnostics (Basel)       Date:  2021-03-22

4.  Intubation with vivasight double-lumen tube versus conventional double-lumen tube in adult patients undergoing lung resection: A retrospective analysis.

Authors:  Manuel Granell; Giulia Petrini; Pablo Kot; Mercedes Murcia; Javier Morales; Ricardo Guijarro; José A de Andrés
Journal:  Ann Card Anaesth       Date:  2022 Jul-Sep

Review 5.  [Application and Research Progress of Video Double-lumen Tube in Thoracic Surgery].

Authors:  Cheng Shen; Peng Liang; Guowei Che
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2022-08-20

6.  A Randomized Controlled Trial Comparing Novel Triple-Cuffed Double-Lumen Endobronchial Tubes with Conventional Double-Lumen Endobronchial Tubes for Lung Isolation.

Authors:  Namo Kim; Hyo-Jin Byon; Go Eun Kim; Chungon Park; Young Eun Joe; Sung Min Suh; Young Jun Oh
Journal:  J Clin Med       Date:  2020-04-01       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.